BCG Vaccine Protects Type 1 Diabetics Against COVID-19

Researchers at Massachusetts General Hospital (MGH), published a new paper in Cell Reports Medicine demonstrating the protective potential of multiple doses of the Bacillus Calmette-Guerin (BCG) vaccine against COVID-19 and other infectious diseases. In a double-blind, placebo-controlled study of patients with type 1 diabetes conducted at the start of the pandemic (before […]